Literature DB >> 31969049

Cost-utilization of peripheral intravenous cannulation in hospitalized adults: An observational study.

Fredericus Hj van Loon1,2, Tina Leggett3, Arthur Ra Bouwman2,4, Angelique Tm Dierick-van Daele5,6.   

Abstract

AIM: In modern healthcare there is increased focus on optimizing efficiency for every treatment or performed procedure, of which reduction of costs is an important part. With this study, authors aimed to calculate the cost of peripheral intravenous cannulation including all components that influence its price.
METHODS: This observational cost-utilization study was conducted between May and October 2016. Hospitalized adults were included in this study, who received usual care. Peripheral intravenous cannulation was carried out according to current hospital protocols, based on international standards for peripheral intravenous catheter insertion. Device costs were assumed equal to the number of attempts multiplied by the fixed supply costs and applicable costs for additional attempts, whereas personnel costs for both nurses and physicians were based on their hourly salary.
RESULTS: A total of 1512 patients were included in this study, with a mean of 1.37 (±0.77) attempts and a mean time of 3.5 (±2.7) min were needed for a successful catheter insertion. Adjusted mean costs for peripheral intravenous cannulation were estimated to be €11.67 for each patient, but costs increase as the number of attempts for successful cannulation increases. The cost for patients with a successful first attempt was lower, at approximately €9.32 but increased markedly to €65.34 when five attempts were needed.
CONCLUSION: Prevention of multiple attempts may lower the costs, and furthermore, additional technologies applied by nurses to individual patients based on predicted difficult intravenous access will make the application of these additional technologies, in turn, more efficient.

Entities:  

Keywords:  Catheterization; costs and costs analysis; economics; peripheral; vascular access devices

Mesh:

Year:  2020        PMID: 31969049     DOI: 10.1177/1129729820901653

Source DB:  PubMed          Journal:  J Vasc Access        ISSN: 1129-7298            Impact factor:   2.283


  5 in total

1.  Cost-effectiveness analysis of bundled innovative devices versus standard approach in the prevention of unscheduled peripheral venous catheters removal due to complications in France.

Authors:  Franck Maunoury; Bertrand Drugeon; Matthieu Boisson; Nicolas Marjanovic; Raphael Couvreur; Olivier Mimoz; Jeremy Guenezan
Journal:  PLoS One       Date:  2022-06-14       Impact factor: 3.752

2.  Intravenous versus intramuscular prophylactic oxytocin for the third stage of labour.

Authors:  Olufemi T Oladapo; Babasola O Okusanya; Edgardo Abalos; Ioannis D Gallos; Argyro Papadopoulou
Journal:  Cochrane Database Syst Rev       Date:  2020-11-09

3.  Peripheral intravenous catheter insertion and use of ultrasound in patients with difficult intravenous access: Australian patient and practitioner perspectives to inform future implementation strategies.

Authors:  Jessica A Schults; Pauline Calleja; Eugene Slaughter; Rebecca Paterson; Claire M Rickard; Catriona Booker; Nicole Marsh; Mary Fenn; Jenny Kelly; Peter J Snelling; Joshua Byrnes; Gerben Keijzers; Marie Cooke
Journal:  PLoS One       Date:  2022-06-24       Impact factor: 3.752

4.  Nurses' Involvement in the Development and Usability Assessment of an Innovative Peripheral Intravenous Catheterisation Pack: A Mix-Method Study.

Authors:  Paulo Santos-Costa; Mariana Alves; Carolina Sousa; Liliana B Sousa; Filipe Paiva-Santos; Rafael A Bernardes; Filipa Ventura; Anabela Salgueiro-Oliveira; Pedro Parreira; Margarida Vieira; João Graveto
Journal:  Int J Environ Res Public Health       Date:  2022-09-05       Impact factor: 4.614

5.  Risk Factors for Difficult Peripheral Intravenous Cannulation. The PIVV2 Multicentre Case-Control Study.

Authors:  Miguel Angel Rodriguez-Calero; Joan Ernest de Pedro-Gomez; Luis Javier Molero-Ballester; Ismael Fernandez-Fernandez; Catalina Matamalas-Massanet; Luis Moreno-Mejias; Ian Blanco-Mavillard; Ana Belén Moya-Suarez; Celia Personat-Labrador; José Miguel Morales-Asencio
Journal:  J Clin Med       Date:  2020-03-15       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.